By Mike Bassett
Source Medpagetoday
Breast cancer screening and new treatments were associated with a large reduction in mortality from the disease over the past 45 years, according to results from a simulation model-based study.
Using four models, the combination of screening, stage I to III disease treatment, and metastatic disease treatment was associated with a 58% reduction in breast cancer mortality from 1975 to 2019, reported Jennifer L. Caswell-Jin, MD, of Stanford University School of Medicine in California, and colleagues in JAMA.
Read more https://www.medpagetoday.com/hematologyoncology/breastcancer/108263